Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

VKTX holding history

Viking Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings

Shares (Q2 2026)
1,605,994
Value
$62.6M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of VKTX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,605,994$62.6M<0.1%−70,719−4.2%ReducedHolders
Q1 20261,676,713$54.6M<0.1%−41,780−2.4%ReducedHolders
Q4 20251,718,493$60.5M<0.1%+1,557,136+965.0%AddedHolders
Q3 2025161,357$4.24M<0.1%−44,116−21.5%ReducedHolders
Q2 2025205,473$5.45M<0.1%−120,821−37.0%ReducedHolders
Q1 2025326,294$7.88M<0.1%+224,051+219.1%AddedHolders
Q4 2024102,243$4.11M<0.1%−354,217−77.6%ReducedHolders
Q3 2024456,460$28.9M<0.1%−69,042−13.1%ReducedHolders
Q2 2024525,502$27.9M<0.1%+449,760+593.8%AddedHolders
Q1 202475,742$6.21M<0.1%−39,893−34.5%ReducedHolders
Q4 2023115,635$2.15M<0.1%+29,655+34.5%AddedHolders
Q3 202385,980$951.8K<0.1%−244,942−74.0%ReducedHolders
Q2 2023330,922$5.36M<0.1%−519,133−61.1%ReducedHolders
Q1 2023850,055$14.2M<0.1%−101,185−10.6%ReducedHolders
Q4 2022951,240$8.94M<0.1%+937,374+6,760.2%AddedHolders
Q3 202213,866$38.0K<0.1%−3,434−19.8%ReducedHolders
Q2 202217,300$50.0K<0.1%−158,978−90.2%ReducedHolders
Q1 2022176,278$529.0K<0.1%+176,278NewHolders
Q3 20210$00.0%−16,273−100.0%Sold outHolders
Q2 202116,273$97.0K<0.1%−2,966−15.4%ReducedHolders
Q1 202119,239$122.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.